Azithromycin metabolite identification in plasma, bile, and tissues of the ball python (Python regius)

Journal of Veterinary Pharmacology and Therapeutics

Volumn 26, Issue 2, 2003, Pages 117-121

  Hunter, Robert P ^a   Koch, D E ^a   Coke, R L ^a,b   Goatley, M A ^a   Isaza, R ^a  

^a KANSAS STATE UNIVERSITY   (United States)

^b San Antonio Zoo   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3' DESAMIN 3 ENE AZITHROMYCIN; 3' DESAMIN 3 ENE DESCLADINOSE AZITHROMYCIN; 3' N NITROSO 9A N NORAZITHROMYCIN; 3' N NOR 3' O NORAZITHROMYCIN; 3' N NOR 9A N NORAZITHROMYCIN; ANTIBIOTIC AGENT; AZITHROMYCIN; DESCLADINOSE AZITHROMYCIN; DESCLADINOSE DEHYDROXY 2 ENE AZITHROMYCIN; DRUG METABOLITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAT; CONTROLLED STUDY; DOG; DRUG BILE LEVEL; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG IDENTIFICATION; DRUG METABOLISM; FEMALE; KIDNEY PARENCHYMA; LIVER; LUNG; MALE; NONHUMAN; PRIORITY JOURNAL; SKIN; SNAKE; SPECIES DIFFERENCE; TISSUE BLOOD FLOW;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BILE; BOIDAE; CROSS-OVER STUDIES; FEMALE; INJECTIONS, INTRAVENOUS; KIDNEY; LIVER; LUNG; MALE; SKIN;

ANIMALIA; CANIS FAMILIARIS; FELIS CATUS; PYTHON REGIUS; PYTHONIDAE; SERPENTES;

EID: 0037393895     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2885.2003.00464.x     Document Type: Article

References (20)

1. Amacher, D.E., Schomaker, S.J. & Retsema, J.A. (1991) Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P-450. Antimicrobial Agents and Chemotherapy, 35, 1186-1190.
2. Avery, M.J., Ferraina, R.A., Shepard, R.M. & Fouda, H.G. (1992) Confirmation and identification of azithromycin metabolites in the dog by HPLC/atmospheric pressure ionization MS/MS. The 40th American Society Mass Spectrometry Conference on Mass Spectrometry and Allied Topics, 40, 1875-1876.
3. Bright, G.M., Nagel, A.A., Bordner, J. et al. (1988) Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-aza-9a-homoerythromycin A derivatives: a new class of macrolide antibiotics, the azalides. Journal of Antibiotics, 41, 1029-1047.
4. Champney, W.S. & Burdine, R. (1998) Azithromycin and clarithromycin inhibition of 50S ribosomal subunit formation in Staphylococcus aureus cells. Current Microbiology, 36, 119-123.
5. Coke, R.L., Hunter, R.P., Isaza, R., Koch, D.E, Goatley, M.A. & Carpenter, J.W. (2003) Pharmacokinetics and tissue concentrations of azithromycin in ball pythons (Python regius). American Journal of Veterinary Research, 64, 225-228.
6. Davis, J.L., Gardner, S.Y., Jones, S.L., Schwabenton, B.A. & Papich, M.G. (2002) Pharmacokinetics of azithromycin in foals after i.v. and oral dose and disposition into phagocytes. Journal of Veterinary Pharmacology and Therapeutics, 25, 99-104.
7. Evans, H.E. (1986) Introduction and anatomy. In Zoo and Wild Animal Medicine, 2nd edn. Ed. Fowler, M.E. pp. 108-132. W.B. Saunders Co., Philadelphia.
8. Fouda, H.G., Shepard, R.M., Ferraina, R.A. & Mullins, M.A. (1990) Atmospheric pressure HPLC/MS/MS identification of azithromycin rat biliary metabolites. The 38th American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics, 38, 383-384.
9. Foulds, G., Shepard, R.M. & Johnson, R.B. (1990) The pharmacokinetics of azithromycin in human serum and tissues. Journal of Antimicrobial Chemotherapy, 25(Suppl. A), 73-82.
10. Girard, A.E., Girard, D., English, A.R., Gootz, T.D., Cimochowski, C.R., Faiella, J.A., Haskell, S.L. & Retsema, J.A. (1987) Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution. Antimicrobial Agents and Chemotherapy, 31, 1948-1954.
11. Hamilton-Miller, J.M.T. (1992) In-vitro activities of 14-. 15- and 16-membered macrolides against Gram-positive cocci. Journal of Antimicrobial Chemotherapy. 29, 141-147.
12. Hardy, D.J., Hensey, D.M., Beyer, J.M., Vojtko C., McDonald, E.J. & Fernandes, P.B. (1988) Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides. Antimicrobial Agents and Chemotherapy, 32, 1710-1719.
13. Hunter, R.P., Lynch, M.J., Ericson, J.F., Millas, W.J., Fletcher, A.M., Ryan, N.I. & Olson, J.A. (1995) Pharmacokinetics, oral bioavailability and tissue distribution of azithromycin in cats. Journal of Veterinary Pharmacology and Therapeutics, 18, 38-46.
14. Peters, D.H., Friedel, H.A. & McTavish, D. (1992) Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties, and clinical efficacy. Drugs, 44, 750-799.
15. Retsema, J., Girard, A., Schelkly, W., Manousos, M., Anderson, M., Bright, G., Borovoy, R., Brennan. L. & Mason, R. (1987) Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. Antimicrobial Agents and Chemotherapy, 31, 1939-1947.
16. Schentag, J.J. & Ballow, C.H. (1991) Tissue-directed pharmacokinetics. American Journal of Medicine. 91(Suppl. 3A), 5S-11S.
17. Secor, S.M., Stein, E.D. & Diamond, J. (1994) Rapid upregulation of snake intestine in response to feeding: a new model of intestinal adaptation. American Journal of Physiology, 266, G695-G705.
18. Sedgwick, C.J. & Borkowski, R. (1996) Allometric scaling: extrapolating treatment regimens for reptiles. In Reptile Medicine and Surgery. Ed. Mader, D.R. pp. 235-241. W.B. Saunders Co., Philadelphia.
19. Shepard, R.M. & Falkner, P.C. (1990) Pharmacokinetics of azithromycin in rats and dogs. Journal of Antimicrobial Chemotherapy, 25(Suppl. A), 49-60.
20. Shepard, R.M., Pouda, H.G., Ferraina, R.A. & Mullins, M.A. (1990) Disposition and metabolism of azithromycin in rats, dogs, and humans. Proceedings of International Congress for Infections Diseases, p. 173, Montreal, Canada, July 1990.